Phase I results for endothelin antagonist discussed at ASCO meeting; phase II trials under way May 19, 1999 No Comments
BASF patents new tyrosine kinase inhibitors for hyperproliferative and angiogenic disorders May 19, 1999 No Comments
Orally active antimetabolite CS-682 well tolerated in patients with refractory solid tumors May 18, 1999 No Comments
Pharmacokinetics of AG-2034 examined in patients; results reported at ASCO meeting May 18, 1999 No Comments
U.S. university research team designs potent and selective inhibitors of PGGTase-I May 18, 1999 No Comments
Synthetic histone deacetylase inhibitor with potent antitumor effects developed in Japan May 18, 1999 No Comments
Rebeccamycin analogue NSC-655649 evaluated in adult and pediatric cancer patients May 18, 1999 No Comments
RSS